| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 09/10/2013 | CA2614544C Heterocycle-substituted benzimidazole derivative |
| 09/10/2013 | CA2579501C Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
| 09/10/2013 | CA2559303C Processes and intermediates for the preparation of aspartic acetal caspase inhibitors |
| 09/06/2013 | WO2013130976A1 Serine/threonine kinase inhibitors |
| 09/06/2013 | WO2013130962A1 Benzofuran- 2 - sulfonamide derivatives as chemokine receptor modulators |
| 09/06/2013 | WO2013128465A1 Cyclic amide derivatives as inhibitors of 11 - beta - hydroxysteroid dehydrogenase and uses thereof |
| 09/06/2013 | WO2013128421A1 Spirohydantoin compounds and their use as selective androgen receptor modulators |
| 09/06/2013 | WO2013128378A1 Phenyl alkanoic acid derivatives as gpr agonists |
| 09/06/2013 | WO2013127729A1 6 - alkynyl pyridines as smac mimetics |
| 09/06/2013 | WO2013127268A1 Amido-benzyl sulfone and sulfonamide derivatives |
| 09/05/2013 | US20130231378 INHIBITORS OF AkT ACTIVITY |
| 09/05/2013 | US20130231367 Beta2-adrenoreceptor agonists |
| 09/05/2013 | US20130231339 Benzofuran-2-sulfonamides pyridine derivatives as chemokine receptor modulators |
| 09/05/2013 | US20130231338 Benzofuran-2-sulfonamides derivatives as chemokine receptor modulators |
| 09/05/2013 | US20130231325 Aldh-2 inhibitors in the treatment of addiction |
| 09/05/2013 | US20130230501 Cycloalkyl-Substituted Imidazole Derivative |
| 09/04/2013 | EP2634177A1 Tau imaging probe |
| 09/04/2013 | EP2634174A2 Nitrogen-containing hetercyclic derivate having 2-imino group and pest control agent including the same |
| 09/04/2013 | EP2632915A1 Benzimidazole inhibitors of leukotriene production |
| 09/04/2013 | EP2632897A1 Indole derivatives and process for their preparation |
| 09/04/2013 | EP2632465A1 Inhibitors of the renal outer medullary potassium channel |
| 09/04/2013 | EP2632268A2 Novel compounds that are erk inhibitors |
| 09/04/2013 | EP2374798B1 Benzazepine derivatives useful as vasopressin antagonists |
| 09/04/2013 | CN103282360A Cxcr4受体拮抗剂 Cxcr4 receptor antagonist |
| 09/04/2013 | CN103282358A Cyp11b, cyp17, and/or cyp21 inhibitors |
| 09/04/2013 | CN103282352A Benzamides and nicotinamides as syk modulators |
| 09/04/2013 | CN103275074A Olmesartan derivative and preparation method thereof |
| 09/04/2013 | CN103275073A 2-(1,2,4-triazole-1-methyl)-2-(coumarone-5-radical)-1,3-dioxolane and application thereof |
| 09/04/2013 | CN103275072A Preparation method of saracatinib |
| 09/04/2013 | CN103275071A Coumarin derivative as well as preparation method and use thereof |
| 09/04/2013 | CN103275070A Tetracyclic compound for adjusting proliferation of mononuclear cells and application of tetracyclic compound |
| 09/04/2013 | CN103275022A 1-benzyl-1, 2, 3-triazole compound, as well as preparation method and application thereof |
| 09/04/2013 | CN103275016A Synthetic method of 2-subsituted quinazoline compounds |
| 09/04/2013 | CN103275011A Novel method for synthesizing imidazolidine heterocycle |
| 09/04/2013 | CN103274993A Novel synthesis method of dihydropyridine and pyrrole heterocyclic rings |
| 09/04/2013 | CN102432566B 2-(4-phenoxyphenyl)oxirane and preparation method and application thereof |
| 09/04/2013 | CN102267948B Fluoreno diimidazole derivatives and preparation method thereof |
| 09/04/2013 | CN102174040B Preparation method of electronic grade triglycidyl isocyanurate |
| 09/04/2013 | CN102007122B Imidazolyl biphenyl imidazoles as hepatitis c virus inhibitors |
| 09/03/2013 | US8524910 Pyridyl derivatives as CFTR modulators |
| 09/03/2013 | US8524909 Tetrahydro-pyran derivatives |
| 09/03/2013 | US8524894 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 09/03/2013 | US8524730 Spirochromanone carboxylic acids |
| 09/03/2013 | US8524728 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| 09/03/2013 | US8524724 Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 09/03/2013 | US8524722 Substituted tricyclic compounds and methods of use thereof |
| 09/03/2013 | US8524721 Platelet ADP receptor inhibitors |
| 09/03/2013 | US8524720 Substituted N-(pyrazol-5-yl)-pyrrolo[3,2-D]pyrimidin-4-amine useful as protein kinase inhibitors |
| 09/03/2013 | US8524711 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/03/2013 | US8524700 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics |
| 09/03/2013 | CA2522562C 2-phenyl-benzimidazol and 2-phenyl-imidazo-`4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer |
| 08/29/2013 | WO2013126797A1 Cholecystokinin b receptor targeting for imaging and therapy |
| 08/29/2013 | WO2013124169A1 Use of 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors |
| 08/29/2013 | WO2013124158A1 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors |
| 08/29/2013 | US20130225825 Process for the preparation of tryptase inhibitors |
| 08/29/2013 | US20130225818 Process for preparing vilazodone hydrochloride |
| 08/29/2013 | US20130225817 Method for manufacture of 2-oxoimidazolidines |
| 08/29/2013 | US20130225619 Substituted heterocyclic compounds for disease treatment |
| 08/29/2013 | US20130225610 Antimetastatic compounds |
| 08/29/2013 | US20130225606 N-hetarylmethyl pyrazolylcarboxamides |
| 08/29/2013 | US20130225596 Novel heterocyclic derivative and pharmaceutical composition comprising the same (as amended) |
| 08/29/2013 | US20130225587 Compound for increasing kinase active and application thereof |
| 08/29/2013 | US20130225580 Aza-aryl 1h-pyrazol-1-yl benzene sulfonamides |
| 08/29/2013 | US20130225579 Cyanoquinoline derivatives |
| 08/29/2013 | US20130225578 7-cyclylquinazoline derivatives and methods of use thereof |
| 08/29/2013 | US20130225573 Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease |
| 08/29/2013 | US20130225567 5-Alkynyl Pyridine |
| 08/29/2013 | US20130225562 Pyridyltriazoles |
| 08/29/2013 | US20130225548 Pyridine Derivative and Medicinal Agent |
| 08/29/2013 | US20130225530 Wogonin for the prevention and therapy of cardiac hypertrophy |
| 08/29/2013 | US20130225524 Chemical Compounds |
| 08/29/2013 | US20130224760 Zinc-Responsive Peptides, and Methods of Use Thereof |
| 08/29/2013 | US20130224195 Substituted benzazoles and methods of their use as inhibitors of raf kinase |
| 08/29/2013 | US20130224107 Heterocyclic derivates, preparation processes and medical uses thereof |
| 08/28/2013 | EP2630682A1 Organic electroluminescent device |
| 08/28/2013 | EP2630140A1 Organic electroluminescent device |
| 08/28/2013 | EP2630139A1 Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors |
| 08/28/2013 | EP2630135A1 1-(heterocyclic carbonyl) piperidines |
| 08/28/2013 | EP2630134A1 Pyridine- 2- derivatives as smoothened receptor modulators |
| 08/28/2013 | EP2630130A1 Method for preparing substituted n-(3-amino-quinoxalin-2-yl)-sulfonamides and their intermediates n-(3-chloro-quinoxalin-2-yl)sulfonamides |
| 08/28/2013 | EP2630129A1 Quinoxaline derivates |
| 08/28/2013 | EP2630128A1 Viral polymerase inhibitors |
| 08/28/2013 | EP2630123A1 Substituted 6-amino-nicotinamides as kcnq2/3 modulators |
| 08/28/2013 | EP2630122A1 Arylamide derivatives as ttx-s blockers |
| 08/28/2013 | EP2629616A2 Substituted amino-triazolyl pde10 inhibitors |
| 08/28/2013 | CN103270032A Aromatic heterocycle derivative and organic electroluminescent element using same |
| 08/28/2013 | CN103270027A Method for preparing substituted n-3-amino-quinoxalin-<wbr/>2-yl)-sulfonamides and their intermediates n-<wbr/>(3-chloro-quinoxalin-<wbr/>2-yl)sulfonamides |
| 08/28/2013 | CN103270024A Novel substituted isoquinoline derivative |
| 08/28/2013 | CN103265535A Antitumor compounds, preparation method and application thereof |
| 08/28/2013 | CN103265517A 3-substituted coumarin derivative and use thereof |
| 08/28/2013 | CN103265477A Aminoheteroaryl compounds as protein kinase inhibitors |
| 08/28/2013 | CN103263417A Itraconazole isomer and medical application thereof |
| 08/28/2013 | CN102321079B (-) doxazosin mesylate crystal VI as well as preparation method and application thereof |
| 08/28/2013 | CN102321078B Doxazosin mesylate III form crystal, and preparation method and usage thereof |
| 08/28/2013 | CN102190625B Stilbene tumor targeted medicine Combretastatin A4 analogs |
| 08/28/2013 | CN101981006B Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 08/28/2013 | CN101535276B Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors |
| 08/27/2013 | US8519164 Process and intermediate compounds useful in the preparation of statins |
| 08/27/2013 | US8519159 Tri-substituted 2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-OL and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-OL analogues, and novel 3,6-disubstituted pyran derivatives |
| 08/27/2013 | US8519142 Aryl pyridine as aldosterone synthase inhibitors |